CD8A and neoplasm: Tumor cells reshape the TME through metabolic processes like aerobic glycolysis (Warburg effect), creating an acidic environment that hampers CD8+ T cell cytotoxicity and proliferation, inhibiting immunotherapy sensitivity [95].